title: Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior.
abstract: BACKGROUND
  Histiocytic malignancies in both humans and dogs are rare and poorly understood. While canine histiocytic sarcoma (HS) is uncommon in the general domestic dog population, there is a strikingly high incidence in a subset of breeds, suggesting heritable predisposition. Molecular cytogenetic profiling of canine HS in these breeds would serve to reveal recurrent DNA copy number aberrations (CNAs) that are breed and/or tumor associated, as well as defining those shared with human HS. This process would identify evolutionarily conserved cytogenetic changes to highlight regions of particular importance to HS biology.
  
  
  METHODS
  Using genome wide array comparative genomic hybridization we assessed CNAs in 104 spontaneously occurring HS from two breeds of dog exhibiting a particularly elevated incidence of this tumor, the Bernese Mountain Dog and Flat-Coated Retriever. Recurrent CNAs were evaluated further by multicolor fluorescence in situ hybridization and loss of heterozygosity analyses. Statistical analyses were performed to identify CNAs associated with tumor location and breed.
  
  
  RESULTS
  Almost all recurrent CNAs identified in this study were shared between the two breeds, suggesting that they are associated more with the cancer phenotype than with breed. A subset of recurrent genomic imbalances suggested involvement of known cancer associated genes in HS pathogenesis, including deletions of the tumor suppressor genes CDKN2A/B, RB1 and PTEN. A small number of aberrations were unique to each breed, implying that they may contribute to the major differences in tumor location evident in these two breeds. The most highly recurrent canine CNAs revealed in this study are evolutionarily conserved with those reported in human histiocytic proliferations, suggesting that human and dog HS share a conserved pathogenesis.
  
  
  CONCLUSIONS
  The breed associated clinical features and DNA copy number aberrations exhibited by canine HS offer a valuable model for the human counterpart, providing additional evidence towards elucidation of the pathophysiological and genetic mechanisms associated with histiocytic malignancies. Extrapolation of data derived from canine histiocytic disorders to human histiocytic proliferation may help to further our understanding of the propagation and cancerization of histiocytic cells, contributing to development of new and effective therapeutic modalities for both species.
authors: Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA.
authors: Benoit
authors: B
authors: Hedan
authors: Rachael
authors: R
authors: Thomas
authors: Alison
authors: A
authors: Motsinger-Reif
authors: Jerome
authors: J
authors: Abadie
authors: Catherine
authors: C
authors: Andre
authors: John
authors: J
authors: Cullen
authors: Matthew
authors: M
authors: Breen
references: Leukemia. 2007 Jan;21(1):184-7
references: 16990767
references: Cytogenet Genome Res. 2008;122(2):110-21
references: 19096206
references: Mutat Res. 2005 Aug 25;576(1-2):22-38
references: 15878778
references: Cancer Cell. 2006 May;9(5):379-90
references: 16697958
references: Cell. 2000 Feb 18;100(4):387-90
references: 10693755
references: Vet Pathol. 2000 Jan;37(1):54-61
references: 10643981
references: Cancer Cell. 2003 Feb;3(2):117-30
references: 12620407
references: Biotechniques. 2001 Jul;31(1):24-6, 28
references: 11464515
references: Cancer Genet Cytogenet. 1986 Mar 1;21(1):85-91
references: 3510716
references: PLoS One. 2007 Dec 19;2(12):e1324
references: 18091995
references: Cancer Genomics Proteomics. 2008 Mar-Apr;5(2):123-36
references: 18460741
references: Biochim Biophys Acta. 1998 Oct 14;1378(2):F115-77
references: 9823374
references: Eur J Haematol. 2003 May;70(5):315-8
references: 12694168
references: Chromosome Res. 2008;16(1):145-54
references: 18293109
references: J Small Anim Pract. 1995 Mar;36(3):93-8
references: 7783441
references: Vet Pathol. 2002 Jul;39(4):458-72
references: 12126149
references: J Neurooncol. 2009 Sep;94(3):333-49
references: 19333554
references: Histopathology. 2002 Jul;41(1):1-29
references: 12121233
references: Genome Res. 2005 Dec;15(12):1831-7
references: 16339382
references: Cancer Genet Cytogenet. 1983 Aug;9(4):317-27
references: 6871836
references: J Hered. 2007;98(5):474-84
references: 17702974
references: Nat Rev Genet. 2010 Jul;11(7):459-63
references: 20548291
references: Nature. 2005 Dec 8;438(7069):803-19
references: 16341006
references: Br J Haematol. 2009 Jan;144(2):266-8
references: 19016723
references: Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9654-9
references: 11481442
references: Hum Pathol. 2003 Dec;34(12):1345-9
references: 14691922
references: Vet Pathol. 2006 Sep;43(5):632-45
references: 16966440
references: Curr Mol Med. 2003 Nov;3(7):605-29
references: 14601636
references: Med Pediatr Oncol. 1997 Sep;29(3):157-66
references: 9212839
references: Mol Cell Endocrinol. 2006 Jun 27;252(1-2):207-15
references: 16650523
references: Nat Rev Immunol. 2002 Mar;2(3):151-61
references: 11913066
references: Am J Hum Genet. 2003 Jun;72(6):1492-1504
references: 12817591
references: Crit Rev Oncol Hematol. 2008 Jan;65(1):1-7
references: 17658269
references: Hum Pathol. 2002 May;33(5):555-60
references: 12094383
references: Vet Comp Oncol. 2006 Jun;4(2):63-74
references: 19754816
references: Bioinformatics. 2004 Dec 12;20(18):3636-7
references: 15201182
references: Cancer Genet Cytogenet. 2007 Jul 15;176(2):100-6
references: 17656251
references: Vet Pathol. 1986 Jan;23(1):1-10
references: 3946051
references: PLoS One. 2009 May 20;4(5):e5549
references: 19461996
references: Nat Genet. 2008 May;40(5):491-2
references: 18443580
references: J Pediatr Hematol Oncol. 2002 Dec;24(9):733-6
references: 12468914
references: Cancer. 1983 Oct 1;52(7):1229-36
references: 6883287
references: Vet Pathol. 2002 Jan;39(1):74-83
references: 12102221
references: Cell. 2006 Oct 20;127(2):265-75
references: 17055429
references: Am J Hum Genet. 2000 Jul;67(1):170-81
references: 10827107
references: J Hered. 2009 Jul-Aug;100 Suppl 1:S19-27
references: 19531730
references: J Vet Med Sci. 2007 Mar;69(3):271-8
references: 17409643
references: Vet Comp Oncol. 2009 Jun;7(2):115-21
references: 19453365
references: Pediatr Blood Cancer. 2011 Feb;56(2):307-10
references: 20973102
references: Genomics. 2004 Sep;84(3):550-4
references: 15498461
references: Vet Pathol. 2007 Jul;44(4):467-78
references: 17606508
references: Leuk Lymphoma. 2003 Sep;44(9):1469-75
references: 14565646
references: Chromosome Res. 1999;7(5):401-6
references: 10515215
references: Vet Rec. 2006 Jun 17;158(24):825-9
references: 16782856
references: J Am Vet Med Assoc. 1986 May 1;188(9):1041-5
references: 3710888
references: Nat Rev Mol Cell Biol. 2006 Sep;7(9):667-77
references: 16921403
references: J Pediatr Hematol Oncol. 1998 Jan-Feb;20(1):12-7
references: 9482407
references: Nat Rev Cancer. 2007 Apr;7(4):233-45
references: 17361217
references: BMC Genomics. 2004 Sep 13;5:65
references: 15363096
references: Blood. 2002 Jun 1;99(11):4154-9
references: 12010820
references: Vet Pathol. 2005 Sep;42(5):618-32
references: 16145208
references: Hum Pathol. 2007 Apr;38(4):668-72
references: 17367608
references: Chromosome Res. 2009;17(3):365-377
references: 19337847
references: Genet Epidemiol. 2001 Jan;20(1):4-16
references: 11119293